Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Market Cap	36.92B
Revenue (ttm)	5.04B
Net Income (ttm)	-847.23M
Shares Out	4.27B
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,272,993
Average Volume	7,204,234
Open	7.50
Previous Close	7.90
Day's Range	7.50 - 8.65
52-Week Range	1.61 - 8.67
Beta	0.39
RSI	85.02
Earnings Date	Jul 30, 2025

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria.

• Industry: Pharmaceutical Preparations
• Founded: 1957
• Employees: 196
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: NEIMETH

Financial Performance

In 2024, NGX:NEIMETH's revenue was 4.49 billion, an increase of 102.98% compared to the previous year's 2.21 billion. Losses were -885.33 million, -50.75% less than in 2023.